Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

NCT00005962 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Leukemia

Interventions

BIOLOGICAL: sargramostim
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: gemtuzumab ozogamicin
DRUG: liposomal daunorubicin citrate
DRUG: topotecan hydrochloride

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]